Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
17,040
Value
$637.6K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CRNX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,040$637.6K<0.1%−1,816−9.6%ReducedHolders
Q1 202618,856$684.9K<0.1%−1,865−9.0%ReducedHolders
Q4 202520,721$964.6K<0.1%+1,917+10.2%AddedHolders
Q3 202518,804$783.2K<0.1%−3,236−14.7%ReducedHolders
Q2 202522,040$633.9K<0.1%−1,998−8.3%ReducedHolders
Q1 202524,038$806.2K<0.1%−5,051−17.4%ReducedHolders
Q4 202429,089$1.49M<0.1%+9,655+49.7%AddedHolders
Q3 202419,434$993.1K<0.1%+5,730+41.8%AddedHolders
Q2 202413,704$613.8K<0.1%−3,027−18.1%ReducedHolders
Q1 202416,731$783.2K<0.1%+1,655+11.0%AddedHolders
Q4 202315,076$536.4K<0.1%+3,105+25.9%AddedHolders
Q3 202311,971$356.0K<0.1%+1,540+14.8%AddedHolders
Q2 202310,431$188.0K<0.1%+10,431NewHolders
Q1 20230$00.0%−11,222−100.0%Sold outHolders
Q4 202211,222$205.4K<0.1%+913+8.9%AddedHolders
Q3 202210,309$204.0K<0.1%+230+2.3%AddedHolders
Q2 202210,079$188.0K<0.1%−3,480−25.7%ReducedHolders
Q1 202213,559$298.0K<0.1%−3,196−19.1%ReducedHolders
Q4 202116,755$476.0K<0.1%+3,721+28.5%AddedHolders
Q3 202113,034$274.0K<0.1%−3,183−19.6%ReducedHolders
Q2 202116,217$306.0K<0.1%+4,431+37.6%AddedHolders
Q1 202111,786$180.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.